ConductScience.org, home

Paper7053467

Failure of oral trimethoprim-sulfamethoxazole prophylaxis in acute leukemia: isolation of resistant plasmids from strains of Enterobacteriaceae causing bacteremia.

Wilson JM and 1 other. N Engl J Med, 1982. Cited by 131 papers, by iCite.

Cite this record

ConductScience Library. Failure of oral trimethoprim-sulfamethoxazole prophylaxis in acute leukemia: isolation of resistant plasmids from strains of Enterobacteriaceae causing bacteremia. Papers, record 7053467. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7053467

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Failure of oral trimethoprim-sulfamethoxazole prophylaxis in acute leukemia: isolation of resistant plasmids from strains of Enterobacteriaceae causing bacteremia.
PubMed
Journal
N Engl J Med
PubMed
Year
1982
PubMed
Publication types
Case Reports, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
131
iCite
Relative citation ratio, by iCite
7.43
iCite
Revised in PubMed
2013-11-21
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wilson JMJ M
2Guiney DGD G

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Enterobacteriaceae InfectionsMajor topic
LeukemiaMajor topic
PlasmidsMajor topic
SepsisMajor topic
SulfamethoxazoleMajor topic
TrimethoprimMajor topic
Acute Disease
Adult
Agranulocytosis
Anti-Bacterial Agents
Drug Resistance, Microbial
Enterobacteriaceae
Humans
Male

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
GM 28924NIGMS NIH HHSUnited StatesR01GM028924PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 131 citations.

PMIDTitleJournalYearIn PapersSource
22451756Cotrimoxazole-resistant Escherichia coli bacteremia in neutropenic patients at a regional oncology hospital.Can J Infect Dis1992https://conductscience.org/library/papers/22451756PubMed
22416197Reduction in clinical response to empiric antimicrobial therapy of febrile granulocytopenic patients receiving TMP/SMX infection prophylaxis.Can J Infect Dis1992https://conductscience.org/library/papers/22416197PubMed
22258955Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.Cochrane Database Syst Rev2012https://conductscience.org/library/papers/22258955PubMed
10943633Prophylaxis of Pneumocystis carinii pneumonia: too much of a good thing?Thorax2000https://conductscience.org/library/papers/10943633PubMed
8031031Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/8031031PubMed
7181492Monitoring of plasmid-encoded, trimethoprim-resistant dihydrofolate reductase genes: detection of a new resistant enzyme.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/7181492PubMed
6880186Preventing infection in neutropenic cancer patients.West J Med1983https://conductscience.org/library/papers/6880186PubMed
6831337Management of the febrile neutropenic patient.Can Med Assoc J1983https://conductscience.org/library/papers/6831337PubMed
6604030Colistin and trimethoprim-sulfamethoxazole for the prevention of infection in patients with acute non-lymphocytic leukaemia. Decrease in the emergence of resistant bacteria.Infection1983https://conductscience.org/library/papers/6604030PubMed
6423548Selective antimicrobial modulation of the intestinal flora. Prophylaxis against infection in neutropenic patients.Infection1984https://conductscience.org/library/papers/6423548PubMed
6419675Selective decontamination of the digestive tract by pipemidic acid.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6419675PubMed
6397139The digestive tract in immunocompromised patients: importance of maintaining its resistance to colonization, especially in hospital in-patients and those taking antibiotics.Antonie Van Leeuwenhoek1984https://conductscience.org/library/papers/6397139PubMed
3491791Prevention of infection in acute leukemia: a prospective randomized study on the efficacy of two different drug regimens for antimicrobial prophylaxis.Infection1986https://conductscience.org/library/papers/3491791PubMed
3481358Ofloxacin for prevention of bacterial infections in granulocytopenic patients.Infection1987https://conductscience.org/library/papers/3481358PubMed
3300532
Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration.
Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3300532PubMed
2680058Fluoroquinolone antimicrobial agents.Clin Microbiol Rev1989https://conductscience.org/library/papers/2680058PubMed
2654019Prophylactic co-trimoxazole versus norfloxacin in neutropenic children--perspective randomized study.Infection1989https://conductscience.org/library/papers/2654019PubMed
2201257Risk factors for fecal colonization with trimethoprim-resistant and multiresistant Escherichia coli among children in day-care centers in Houston, Texas.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2201257PubMed
2050424Ofloxacin versus trimethoprim-sulfamethoxazole for prevention of infection in patients with acute leukemia and granulocytopenia.Infection1991https://conductscience.org/library/papers/2050424PubMed
1469177Prevention of nosocomial infection in critically ill patients by selective decontamination of the digestive tract. A randomized, double blind, placebo-controlled study.Intensive Care Med1992https://conductscience.org/library/papers/1469177PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7053467

GET https://conductscience.org/api/papers/v1/7053467/authors